Nov 7, 2024 05:18PM
Nov 7, 2024 04:05PM
Aug 8, 2024 04:32PM
Aug 8, 2024 04:05PM
Aug 1, 2024 04:05PM
May 9, 2024 04:38PM
May 9, 2024 04:06PM Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
May 2, 2024 04:05PM
Feb 28, 2024 04:21PM
Feb 28, 2024 04:05PM
Feb 21, 2024 08:01AM
Jan 8, 2024 08:15AM
Jan 8, 2024 08:00AM
Nov 8, 2023 04:50PM Revance Therapeutics (RVNC) Misses Q3 EPS by 92c; Offers Guidance
Nov 8, 2023 04:06PM
Nov 1, 2023 08:00AM
Sep 19, 2023 09:08AM
Sep 19, 2023 09:00AM
Aug 8, 2023 04:43PM
Aug 8, 2023 04:05PM
Aug 1, 2023 08:00AM Revance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
May 9, 2023 04:58PM
May 9, 2023 04:05PM
May 2, 2023 08:00AM
Feb 28, 2023 04:37PM
Feb 28, 2023 04:06PM
Feb 21, 2023 04:05PM
Jan 9, 2023 08:00AM Revance Therapeutics (RVNC) Provides an Update on DAXXIFY Launch, Reports Prelim Q4 Results
Jan 9, 2023 08:00AM
Nov 8, 2022 04:05PM
Nov 1, 2022 08:00AM
Sep 22, 2022 05:36PM
Aug 9, 2022 05:00PM
Aug 9, 2022 04:05PM
Aug 2, 2022 04:05PM Revance to Release Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
May 10, 2022 04:49PM
May 10, 2022 04:05PM
May 3, 2022 08:00AM
Mar 8, 2022 09:20AM
Feb 28, 2022 04:36PM
Feb 28, 2022 04:05PM
Feb 22, 2022 08:00AM Revance to Release Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022
Jan 28, 2022 09:00PM
Jan 23, 2022 09:00PM
Jan 7, 2022 08:03AM
Jan 7, 2022 08:00AM
Nov 9, 2021 04:55PM
Nov 9, 2021 04:05PM
Nov 2, 2021 04:05PM Revance to Release Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
Aug 5, 2021 04:51PM

1,197,369 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All